In the American Joint Committee on Cancer (AJCC) classification, acral lentiginous melanoma (ALM) histotype ALM is not included as an independent prognostic factor; in small series its negative prognostic impact on disease-free survival (DFS) and overall survival (OS) has been linked to the greater Breslow thickness (BT).
Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study / Mandalà, M., Rutkowski, P., Galli, F., Patuzzo, R., De Giorgi, V., Rulli, E., Gianatti, A., Valeri, B., Merelli, B., Szumera-Ciećkiewicz, A., Massi, D., Maurichi, A., Teterycz, P., Santinami, M.. - In: ESMO OPEN. - ISSN 2059-7029. - ELETTRONICO. - 7:(2022), pp. 100469-100469. [10.1016/j.esmoop.2022.100469]
Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study
Massi, DSupervision
;
2022
Abstract
In the American Joint Committee on Cancer (AJCC) classification, acral lentiginous melanoma (ALM) histotype ALM is not included as an independent prognostic factor; in small series its negative prognostic impact on disease-free survival (DFS) and overall survival (OS) has been linked to the greater Breslow thickness (BT).
| File | Dimensione | Formato | |
|---|---|---|---|
|
Mandalà ESMO open.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
1.08 MB
Formato
Adobe PDF
|
1.08 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
